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0014-5793  2012 Federation of European BiochemicSingle nucleotide polymorphisms (SNPs) are one type of genomic DNA variations in a population.
Correspondingly, single amino-acid polymorphisms (SAPs) derived from non-synonymous SNPs rep-
resent protein variations in a population. Recently, using proteomic approaches, SAPs in the plasma
proteomes of an Asian population were systematically identiﬁed for the ﬁrst time. That study
showed that heterozygous and homozygous proteins with various SAPs have different associations
with particular traits in the population. Recent discoveries of widespread differences between RNA
and DNA sequences indicate that RNA editing is also a source of SAPs – one that is independent of
genomic SNPs. Furthermore, we argue that there are de novo SAPs that are not encoded by either
DNA or RNA sequences.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
Since the 2003 completion of the Human Genome Project,
which provided sequencing data at the species level, the scientiﬁc
community has concentrated on genetic variants at the population
level to understand and develop treatments for common complex
diseases such as cancer and diabetes. In the same year, the Interna-
tional HapMap Project was initiated; this project seeks to identify
common patterns of DNA sequence variation in the genomes of hu-
man populations with ancestry in parts of Africa, Asia and Europe
[1]. Single nucleotide polymorphisms (SNPs), resulting from single
base variations, are recognised as the most common type of genetic
variants in the human genome; these variants are often associated
with particular physiological or pathological traits in individuals. It
has been estimated that the human genome contains approxi-
mately 10 million SNPs [2]. In 2005, the International HapMap
Consortium released the ﬁrst version of the haplotype map of the
human genome, in which more than one million SNPs were ana-
lysed [3]; the second version, released in 2007, involved more than
three million SNPs [4].
Currently, millions of SNPs are available for physiological or
pathological association studies. In general, there are two types of
SNPs: functional SNPs, such as those altering an amino sequence
or a transcription factor binding element, and non-functional SNPs,
which are not related to the regulation of protein expression. Tobs.ac.cn (R. Zeng).
al Societies. Published by Elsevieravoid the potential problem associated with the use of non-func-
tional SNPs in association studies, which might result in different
degrees of linkage disequilibrium with functional SNPs among dif-
ferent populations [5], Humphries et al. strongly recommended
using functional SNPs in association studies [6]. Therefore, it is nec-
essary to analyse functional SNPs at the proteome level.
2. Molecular variation in populations from non-synonymous
SNPs to single amino-acid polymorphisms
SNPs can be located either within coding regions or outside cod-
ing regions. Because of the degeneracy of the genetic code, SNPs
within coding regions may not change the amino acid sequence
of the corresponding proteins. Therefore, SNPs within coding re-
gions are further divided into two categories: synonymous SNPs
and non-synonymous SNPs. Non-synonymous SNPs belong to the
previously deﬁned functional category. Recently, Schaefer et al. de-
signed an extensive database of non-synonymous SNPs, called the
SNP database of effects (SNPdbe), which contains 1.3 million total
SNPs corresponding to single amino acid substitutions from three
SNP databases [7].
Several reports have shown that non-synonymous polymor-
phisms resulting in changes in amino acid sequences often have
signiﬁcant impacts on gene functions [8–10]. Yoshiura et al.
showed that SNP rs17822931, a non-synonymous variant (180G/
R) in the ABCC11 gene, was the sole determinant of the human ear-
wax type, whereas the SNPs located in the intron and Alu-repeti-
tive sequence did not have similar effects on this physiologicalB.V. Open access under CC BY-NC-ND license.
2842 J.-R. Wu, R. Zeng / FEBS Letters 586 (2012) 2841–2845trait, even though these SNPs had the same P values as the SNP
rs17822931 in the association study [8]. In a case-control study
with 52608 gene-based tag SNPs selected from the JSNP database,
Kubo et al. determined that the non-synonymous SNP rs2230500
(1425G/A) in exon 9 of the gene PRKCH, a member of protein kinase
C family, can increase the risk of cerebral infarction [9]. A recent
case-control study with a Chinese cohort and biochemical assay
showed that the non-synonymous SNP rs231775 (49G/A) in the
gene CTLA-4, which is involved in the regulation of T-cell activa-
tion, was associated with increased susceptibility to multiple can-
cers, including lung, breast, oesophageal and gastric cancers [10].
In contrast, some non-synonymous SNPs do not affect the func-
tions of genes. For example, the non-synonymous SNP
rs34952165 (122 V/I) in the DNase 1L1 gene was shown to have lit-
tle effect on the DNase activity of the enzyme [11].
To understand the genotype distributions of non-synonymous
SNPs at the population level, Takeshita et al. systematically ana-
lysed 13 non-synonymous SNPs in three apoptosis-related endo-
nuclease genes, ENDOG, DFFB and FEN-1, in 13 different human
populations of healthy Asians, Africans and Caucasians [12]. These
researchers showed that only three non-synonymous SNPs, includ-
ing S12L in the ENDOG gene and R196K and K277R in the DFFB
gene, are polymorphic, whereas the other 10 SNPs are not [12].
Based on their previous works [13–15], Takeshita et al. concluded
that endonucleases exhibit a low degree of genetic heterogeneity
with regard to non-synonymous SNPs [12]. By re-sequencing the
human exomes of 200 individuals from Denmark, Li et al. identiﬁed
53081 SNPs within the coding regions of 18654 well-annotated
genes; half of the identiﬁed coding SNPs were non-synonymous
[16]. These researchers further revealed that there were twice as
many deleterious non-synonymous SNPs as synonymous SNPs in
the low-frequency range, with minor allele frequencies of 2–5%,
implying that low-frequency non-synonymous SNPs can have a
substantial impact on evolutionary ﬁtness [16].
Because non-synonymous SNPs within coding regions must
cause amino-acid variation in proteins during the translational
process, we propose that the speciﬁc properties of these amino
acid variations can only be uncovered by direct analysis at the pro-
tein level. Although SNPs have been studied extensively over the
past decade, little attention has been paid to the amino-acid poly-
morphisms of proteins at the population level. A search of the Pub-
Med database using the term ‘‘SAAP’’ (single amino acid
polymorphism) found only four papers focused on SAAPs [17–
20], of which two papers reported SAAPs identiﬁed by the analysis
of individual protein and vascular tissues, respectively, using pro-
teomic approaches [17,18], and the other two papers provided
SAAP databases generated with bioinformatics tools [19,20]. Re-
cently, we performed the ﬁrst analysis of single amino-acid poly-
morphisms in plasma proteins at the population level, and
coined the term ‘‘SAP’’ to be simpler than ‘‘SAAP’’ and to ﬁt the cor-
responding term ‘‘SNP’’ [21].
To systematically detect SAPs in human plasma based on high-
conﬁdence Swiss-Prot annotation, we ﬁrst constructed a reliable
plasma-related SAP database containing 439 SAPs matched to 29
plasma proteins, and then we analysed the plasma proteomes of
33 plasma samples from Asian individuals using shotgun proteo-
mics [21–23]. We identiﬁed 2154 SAP peptides corresponding to
46 unique SAP peptides [21]. To further uncover the properties of
SAPs at the population level, three pairs of SAP peptides corre-
sponding to complement components C5 and C7 and complement
factor H (CFH) were selected among the identiﬁed SAP peptides for
quantitative analysis in plasma samples from 290 Asian individuals
using a targeted proteomic approach (selected reaction monitor-
ing, SRM), in which the target protein samples were mixed with
stable-isotope labelled peptides and then selectively quantiﬁed
by mass spectrometry [24–26].3. Qualitative and quantitative analysis of SAPs in plasma from
Asian individuals at the population level
For humans and other diploid-genome organisms, an individual
can be either homozygous or heterozygous for a particular SNP
[27,28]. It has been reported that the different genetic structures
of coding SNPs are tightly associated with the physiological and
pathological traits of individuals [8–10,29]. For example, Yoshiura
et al. reported that AA-homozygosity of the non-synonymous SNP
rs17822931 in the ABCC11 gene in Japanese individuals is associ-
ated with dry earwax, whereas GG-homozygosity and GA-hetero-
zygosity are associated with wet earwax [8]. In addition, the
frequency of the homozygous CTLA-4 49AA (non-synonymous
SNP rs231775) genotype was signiﬁcantly higher in Chinese pa-
tients with lung cancer, whereas the heterozygous CTLA-4 49GA
genotype was not associated with lung cancer [10]. Dr. Chess’
group at Harvard Medical School reported widespread monoallelic
expression from human autosomes [30], suggesting that some
SNPs could be distributed with no genetic heterogeneity in the
population. In the case of the FEN-1 gene, all six non-synonymous
SNPs have been detected as entirely monoallelic in the 13 exam-
ined populations [12].
By analysing these three pairs of SAP peptides with the SRM ap-
proach, we showed that the percentage of diabetic and overweight/
obese Chinese individuals heterozygous for the C5 SAPs was signif-
icantly higher than normal individuals, whereas the distributions
of the heterozygotes for C7 and CFH SAPs were not signiﬁcantly
different in these Asian sub-populations [21, Fig. 2A]. We further
showed that the proportion of C7_587P homozygosity in normal
individuals was signiﬁcantly higher than that in individuals with
a metabolic disorder [21, Fig. 2B]. Taken together, these results
suggest that the genetic structures of SAPs at the proteome level
have distribution properties similar to those of SNPs at the genome
level in populations.
In heterozygous individuals, allele-speciﬁc expression of SNPs is
widely detected at the transcriptome level [31–33]. Approximately
11–22% of heterozygous mRNA-associated SNPs exhibited allele-
speciﬁc expression in each of four human cell lines, and 4.3–8.5%
of allele-speciﬁc expression was tissue speciﬁc [34]. This type of al-
lele-speciﬁc expression of heterozygous mRNA-SNPs is often asso-
ciated with physiological and pathological traits in individuals. A
recent report showed that H2-haplotype individuals with TGFBR1
allele-speciﬁc expression were highly susceptible to colorectal can-
cer [35]. Although it is possible to obtain quantitative information
regarding the allele-speciﬁc expression of heterozygous SNPs at
the transcriptional level, understanding polymorphism-related
expression at the proteome level requires a quantitative proteomic
approach. Recently, with a newly developed ﬂuorescent-protein
detection system, Dr. Xie’s group at Harvard University quantita-
tively analysed the correlation between protein and mRNA expres-
sion at single-molecule level and concluded that the protein and
mRNA copy numbers for any given gene are uncorrelated [36]. This
work further strengthens our view that the quantitative analysis of
SAPs at the proteome level is necessary to fully understand the
quantitative properties of genetic polymorphisms, which cannot
be interpreted simply based on the allele-speciﬁc expression of
mRNA-SNPs at the transcriptome level.
Taking advantage of the SRM approach [24–26], we analysed
each SAP peptide of these three pairs of SAPs in the plasma of these
290 Asians in terms of the absolute concentration [21]. This quan-
titative analysis showed that three SAP peptides (C7_587T,
CFH_62 V and CFH_62I) in the homozygous state were signiﬁcantly
associated with metabolic disorders [21, Fig. 3]. We quantitatively
measured the distributions of the three pairs of SAPs in the hetero-
zygous state in all four sub-populations of the examined Asians
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particular physiological and pathological traits [21, Fig. 4].
Our recent study is the ﬁrst to reveal the quantitative properties
of protein-polymorphisms at the population level. We draw three
conclusions from this study: (1) Traditional methods for the analy-
sis of protein expression, such as Western-blotting and ELISA,
which can detect the total concentration of a protein, are unable
to separately measure the absolute concentration of each SAP pro-
tein in heterozygous individuals, but SRM provides a useful tool for
performing this analysis. (2) Each counterpart-SAP of a heterozy-
gous SAP-pair might present differential distributions associated
with physiological or pathological traits, e.g., C7_587T in the het-
erozygotes is associated with obesity and diabetes, whereas
C7_587P is not [21, Fig. 4]. Our recent work analysing more than
one thousand Asian plasma samples using SRM approach revealed
that one SAP peptide of the heterozygous SAP peptide pair in Apoa4
is associated with lower triglyceride levels, whereas its counterpart
is associated with higher triglyceride levels (unpublished data). (3)
The SRM-based analysis of plasma SAPs, particularly heterozygous
polymorphisms, might uncover new biomarkers associated with
particular physiological or pathological traits.
4. Three possible SAP sources: a challenge to the Central Dogma
Originally, the concept of SAPs was derived from the concept of
SNPs on the basis of the Central Dogma of molecular biology
(Fig. 1), whichwas ﬁrst proposed by Crick F. in 1958 [37]. The Central
Dogma describes how genetic information is transferred from the
genome level to the protein level, i.e., the information in gene se-
quences is delivered to the nucleic acids ofmRNAmolecules through
transcription and is then transferred to the amino acids of proteins
according to genetic code through translation. Based on the Central
Dogma, it is a long-standing belief that mRNA sequences must be
faithful to DNA sequences and that the amino acid sequence of the
resultant proteinsmust be faithfully determined by the genetic code.
Therefore, genomic non-synonymous SNPs in coding regions must
be the major source of SAPs according to the Central Dogma.
Although the ‘‘mRNA editing’’ phenomenon that results in
nucleotide variants of mRNA molecules during the transcriptional
process was discovered in the early 1980s [38], this phenomenon
has not destroyed the fundamental belief in the Central Dogma
and is recognised as a rare variation in the genetic information at
the level of transcription. However, Cheung’s group at the Univer-
sity of Pennsylvania recently showed there are widespread RNAGenome Level:
1
1
1
1
Proteome Level:
1
1
2, 
Transcriptome Level:
1, Genomic SNPs
SAP
SAP
mRNA-SNP
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Fig. 1. Three possible sources of SAPs. Schematic illustration of three possible sources of S
2 indicates a RNA-editing dependent SAP-source; and No. 3 indicates a possible SAP-
sequences.and DNA sequence differences in the human transcriptome; more
than 10000 exonic sites did not match the DNA sequences, and
all 12 possible categories of nucleic-acid discordances were ob-
served [39]. Although some scientists argued that Cheung and his
colleagues may have generated a large number of false positives
during their analysis of the sequencing data [40,41], and Schrider
et al. even came to the opposite conclusion by re-analysing the Che-
ung’s dataset [42], more andmore studies have provided strong evi-
dence to support Cheung’s conclusion. Using siRNA-knockdown of
the ADAR protein, which is a well-known RNA-editing enzyme that
catalyses the transformation of adenosine to inosine [43], Bahn et
al. showed that genome-wide DNA–RNA differences were signiﬁ-
cantly inhibited, indicating that the extensive nucleotide variants
at the transcription level are generated through RNA editing mech-
anisms. This collection of edited RNAs was then called the ‘‘RNA
editome’’ [44]. Bahn et al. further indicated that the majority of
RNA editing sites belonged to the A-to-I type, and genes with pre-
dicted A-to-I editing were signiﬁcantly enriched in the category of
cancer-related genes, suggesting the possible existence of cancer-
speciﬁc RNA editing [44]. Another recent report further supported
Bahn’s conclusions and even extended the existence of the RNA edi-
tome to microRNA molecules [45]. Snyder and his colleagues
showed for the ﬁrst time that many RNA edits in peripheral blood
mononuclear cells that were continuously collected from a healthy
individual over 14 months exhibited dynamic and differential
changes during that period, suggesting that the components of
the RNA editome could be dependent on the environment [46].
The discovery of the editome challenges the Central Dogma: there
might be extensive nucleotide variation introduced during the
transmission of the genetic information from the genome to the
transcriptome. As Hayden notes, ‘‘If veriﬁed, the ﬁndings would re-
quire a rewrite of the ‘central dogma’ of molecular biology’’ [41].
In this regard, we propose that RNA editome must be a second
source of SAPs, which is independent on the source of SNPs
(Fig. 1). By globally analysing proteins in human B cells using a pro-
teomic approach, Cheung and his colleagues concluded that, in hu-
man cells, there are peptide sequences that are not exactly
encoded by the DNA coding sequences [39]. In addition, by compar-
ing themass spectra of proteins to the amino acid sequences of pro-
teins with 4586 missense single nucleotide variants (equivalent to
non-synonymous SNPs) and to all 30385 RNA edits, Snyder and col-
leagues identiﬁed peptides corresponding to 48 single nucleotide
variants and 51 edits and concluded that several transcripts
containing RNA edits serve as templates for protein synthesis [46].2
2
3
RNA editome
SAP
SAP
RNA-edit
3, Dysfunction of protein editing
APs. No. 1 indicates the major SAP-source from genomic non-synonymous SNPs; No.
source due to dysfunction of protein editing, which is independent on DNA/RNA
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oxidation and pseudouridylation, that could cause transcriptional
errors are also possible sources of SAPs at the transcriptome level
[47–49].
In contrast to the meaning of RNA editing that causes nucleotide
variation, a term of protein editing means a proofreading of amino
acids during the process of protein synthesis [50,51]. As early as the
1970s, researchers found that aminoacyl-tRNA (aa-tRNA) syntheta-
ses could destroy mislabelled amino acids and hydrolyse mis-
charged tRNAs in the editing domain of the aa-tRNA synthetase
[52]. Subsequently, the structural details of the editing domain
were analysed systematically [reviewed by 53,54]. Recently, an-
other protein-editing mechanism has been uncovered wherein
the ribosome selects correct aa-tRNAs and disregards the incorrect
ones using a so-called induced-ﬁt mechanism [55]. Theoretically,
dysfunctional protein editing should result in the loss of ﬁdelity
during translation. Lee et al. reported that an editing-defective aa-
tRNA synthetase resulted in an increase in the number of mis-
charged tRNAs, which could result in the intracellular accumulation
of misfolded proteins in neurons [56]. By introducing a transgene
expressing an editing-deﬁcient aa-tRNA synthetase into mamma-
lian cells, Nangle et al. detected an increase in the misincorporation
of a particular amino acid into an EGFP-reporter [57]. A higher
translational error rate due to the suppression of protein editing
functions might have a selective advantage during evolution. Li
et al. recently showed that the parasite Mycoplasma naturally has
point mutations and deletions in the editing domains of its aa-tRNA
synthetases, resulting in mistranslations of the parasite proteins
[58]. These researchers proposed that these natural protein-editing
mutations in the parasites might have evolved as a mechanism to
generate antigen diversity to escape host defence systems [58].
It has been estimated that the typical frequencies of mistransla-
tion are approximately 1 per 103  104 codons [54,59]. Based on
this error rate, 18% of proteins having an average length of 400
amino acids contain at least one missense substitution [60]. Be-
cause the analysis of amino-acid variants at the proteome level
has been less extensive than analysis of the RNA editome at tran-
scriptome level so far, the predicted protein variation rate is most
likely underestimated, suggesting that there might be widespread
amino-acid variants in a population. Therefore, we propose a third
source of SAPs, which is independent of SNPs and the RNA editome,
resulting from the dysfunction of protein editing or other unknown
mechanisms related to protein synthesis or post-protein synthesis
processes (Fig. 1). In other words, cells might contain de novo SAPs
that are independent of DNA/mRNA sequences, an idea that again
challenges the Central Dogma at the proteome level.
5. Future perspectives
In light of the recent discovery of the RNA editome, it is likely
that RNA editing is a second source of SAPs, which is independent
of non-synonymous SNPs that are a major source of SAPs. Further-
more, we propose a third source of SAPs: dysfunctional protein
editing or other unknown chemical amino-acid modiﬁcations lead
to de novo SAPs, which is independent of nucleotide sequences and
should form a new area of population variation research (Fig. 1).
The study of SAPs should provide new insight into the Central
Dogma and the relationship between genotype and phenotype.
The study of SAPs could also lead to the identiﬁcation of new
molecular biomarkers that can be used to help treat complex dis-
eases and improve human health.
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